Medication-Assisted Treatment Waiver Training
August 18, 2020
950 S White River Pkwy W Dr
Indianapolis, IN 46221
The event is FREE to attend, however, a registration must be submitted as seating is limited.
- Continental breakfast will be served at 8:00am, as well as lunch later in the day.
- Training will begin promptly at 8:30am.
- Dr. Emily Zarse, MD, will present the 8-hour required training which, upon completion, attendees will receive a certificate to then apply for a MAT Waiver. There is a shortage of providers to fulfill this need, so we encourage all to take advantage of this opportunity.
- This activity will assist physicians, nurses, physician assistants, and psychiatrists who wish to apply for a waiver to prescribe buprenorphine for the treatment of opioid use disorders.
- Download the event flyer HERE.
IRHA has a room block at the Hampton Inn, 105 S. Meridian Street, Indianapolis, for the nights of Sunday, August 16, and Monday, August 17. To make reservations, call 317-261-1200 and use group code RH2. You can also use the following link for online booking:
Once the training is completed, support and guidance to treat patients with Opioid Use Disorder will be available for free from the InROC and Project ECHO. Project ECHO links community-based clinicians with an inter-disciplinary team of specialists, led by the Indiana University School of Medicine, using Zoom videoconferencing technology. Specialists mentor and share their expertise across a virtual network via case-based learning, enabling primary care clinicians to treat patients with OUD in their own communities.
Connect and register with Project ECHO HERE.
Connect with InROC HERE.
Thank you to our wonderful partners for making this training available!
American Association on Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this training.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.